DailyIQ
Last updated 5 minutes ago

MET·MetLife, Inc.

$.
-. (-.%)
High
$93.73
Open
$93.21
Market Cap
60.22B
52W High
$93.81
Low
$93.12
P. Close
$93.70
P/E
16.64
52W Low
$67.33
Fwd P/E
40.39
DailyIQ Est.
$98.40
Technical Score (1D)
95
BUY
News Sentiment
70
BULLISH
MetLife’s latest announcement that it is embedding artificial‑intelligence tools across underwriting, claims and customer‑service operations marks a significant shift in its operating model. By automating routine tasks and enhancing risk‑assessment algorithms, the company aims to streamline processes, cut manual effort and accelerate decision making. The immediate market implication is a potential reduction in operating costs and a tightening of underwriting margins, which could improve profitability over the next 1–10 trading days. Investors should watch for any early earnings guidance that references AI‑driven cost savings or changes in loss ratios, as these figures will validate the strategic benefit. Additionally, keep an eye on regulatory filings for any commentary on AI compliance, since increased scrutiny could affect deployment timelines. Competitors’ responses—particularly any accelerated AI initiatives—could also influence MET’s relative positioning. Finally, monitor any press releases or analyst calls that detail pilot results or customer‑satisfaction metrics, as these will signal the effectiveness of the new technology.
Earnings Summary
MetLife, Inc. is a global financial services provider specializing in life, health, and disability insurance, annuities, employee benefits, and asset management, positioning it as a major player in the financial services sector. In the most recent two quarters, MetLife reported EPS of $2.58 in Q4 2025 and $2.42 in Q1 2026, both beating analyst estimates of $2.37 and $2.27 respectively, while revenue fell from $24.19 billion to $19.68 billion, reflecting a slowdown compared to the flat $17.92 billion and $17.90 billion in Q2 and Q3 2025; the company’s EPS trend has been relatively stable with three out of six quarters beating estimates, though revenue growth has decelerated. Historically, MetLife has shown a modest YoY EPS growth trajectory, with recent quarters indicating consistent earnings beats amid a challenging revenue environment, suggesting resilience in underwriting profitability even as top-line growth moderates. Recent news highlights MetLife’s strategic shift to embed artificial‑intelligence tools across underwriting, claims, and customer‑service operations, a move expected to reduce operating costs and tighten underwriting margins; analysts have responded by raising price targets to $103–$105, underscoring confidence in the insurer’s risk‑adjusted earnings path and dividend policy. Investors should watch for the upcoming Q2 2026 earnings release for early indications of AI‑driven cost savings, changes in loss ratios, and expense trends, as well as any regulatory commentary that could affect deployment timelines or capital requirements; monitoring interest‑rate sensitivity and macro‑economic signals will also be key to assessing the impact on underwriting profitability and shareholder returns.

EPS

EstBeatMiss
$1.87$2.07$2.27$2.47$2.67Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$2.32 - -
Q1'26$2.27$2.42+6.6%
Q4'25$2.37$2.58+9.1%
Q3'25$2.32$2.37+2.2%
Q2'25$2.16$2.02-6.7%
Q1'25$2.01$1.96-2.5%

Revenue

EstBeatMiss
$16.4B$19.7B$23.0B$26.2B$29.5BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$19.6B - -
Q1'26$19.4B$19.7B+1.3%
Q4'25$28.0B$24.2B-13.6%
Q3'25 - $17.9B -
Q2'25 - $17.9B -
Q1'25 - $18.8B -

Market Data

MET Stock Snapshot

MET is currently trading at $93.58, giving MetLife, Inc. a market cap of 60.22B and a P/E ratio of 16.6. Today's range spans $93.12–$93.73, with shares opening at $93.21 and moving down $0.12 (0.1%) from the prior close. DailyIQ's technical score sits at 95/100 (BUY) with a news sentiment reading of 70/100.

Over the past year MET has traded between $67.33 and $93.81 - the current price is +39.0% off the 52-week low and -0.2% from the high. 25 analysts cover the stock with a Buy consensus and a mean 12-month target of $96.00 (range $75.00–$105.00), implying upside of +2.6%.

The bullish case for MET is built on complementary signals: 95/100 technical score, BUY designation, and bullish sentiment at 70/100. At $93.58 (near 52-week highs within $67.33–$93.81), the stock is at a capitalization - 60.22B - where active managers can build meaningful positions without moving the market. (P/E: 16.6) That combination of signal quality and position-buildability makes this one of the more actionable large-cap setups in Financial Services.

Earnings revision cycles in large-cap Financial Services names tend to compound: when technicals confirm a BUY thesis (95/100) and news sentiment (70/100, bullish) supports the narrative, analyst upgrades follow price rather than lead it. At $93.58 (near 52-week highs), MET's position within the $67.33–$93.81 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.